Behavioral side effects include agitation, paranoia, hallucinations, delusions, and violence, as well as suicidal and homicidal thinking. They can be primary to the drug’s effect or secondary to exacerbation of comorbid psychiatric disorders. 45 Methamphetamine is a highly addictive psychostimulant chemically related to amphetamine. In the central nervous system, amphetamines block presynaptic reuptake of catecholamines, such as dopamine and norepinephrine, causing hyperstimulation at selected postsynaptic neurons. Other noncatecholaminergic central nervous pathways are hyperstimulated. CNS dopaminergic alterations cause changes in mood, excitation, motor and sensory movements, and appetite. Serotonin effects are thought to contribute to mood changes and psychotic and aggressive behavior. Methamphetamine is inexpensive and readily synthesized from cheap chemicals, such as pseudoephedrine, anhydrous ammonia, red phosphorus, and hydrochloric acid. 46 Snorting or smoking methamphetamine causes excessive tooth and gum disease (meth mouth); snorting methamphetamine causes anosmia and deviated septum; smoking this drug causes lung and airway damage. In recent years, methamphetamine- Stimulant intoxication As in other situations, behavioral and psychological changes occur in stimulant intoxication. Auditory hallucinations or paranoid ideations may be prominent. Signs and symptoms of intoxication develop during or shortly after use, including: ● Tachycardia or bradycardia. ● Pupillary dilation. ● Elevated or lowered blood pressure. ● Perspiration or chills. ● Nausea or vomiting. ● Evidence of weight loss. ● Psychomotor agitation or retardation. Stimulant withdrawal The essential feature of stimulant withdrawal is characterized by the development of dysphoria along with: ● Fatigue. Treatment of stimulant use disorder Evidence is lacking for pharmacological treatment of stimulant use disorder. Interventions with multiple treatments including antidepressants, anticonvulsants, disulfiram, and opioid agonists have been studied and there currently is insufficient evidence to support their routine use. The strongest evidence-based approach for the treatment of stimulant use disorder remains behavioral interventions including contingency management. Contingency management includes the strategy of rewarding positive behavior and reaching a specific achievement such as abstinence, ● Vivid, unpleasant dreams. ● Insomnia or hypersomnia. ● Increased appetite. ● Psychomotor retardation or agitation.
involved overdoses have been increasing in the United States across many demographic groups. 47 MDMA , commonly known as ecstasy ( E or X ), is derived from methamphetamine. MDMA is an indirect sympathomimetic which stimulates the release and inhibits the reuptake of epinephrine, norepinephrine, and dopamine. MDMA can cause tachycardia, elevated blood pressure, mydriasis, increased energy, anorexia, and increased concentration. Adverse effects can include nausea, diaphoresis, anorexia, myoclonus tremors, tics, paresthesia, nystagmus, hyperreflexia, hypertension, urinary retention, and ataxia. 43 Bath salts (synthetic cathinones) are designer drugs derived from naturally occurring amphetamine analogs found in the Catha edulis plant. Cathinones stimulate the release and block the reuptake of norepinephrine, dopamine, and serotonin at synapses in the brain, producing stimulant effects similar to cocaine and amphetamines. Commonly abused substituted cathinones include mephedrone, methylenedioxypyrovalerone, and methylone, although the composition in bath salts sold for use by abusers varies widely. ● Muscular weakness, respiratory depression, chest pain, or cardiac arrhythmias. ● Confusion, seizures, dyskinesias, dystonias, or coma. Stimulant intoxication is not a criterion for substance use disorder. A specific antidote does not exist, and supportive treatment is recommended in the case of an overdose. The careful use of benzodiazepines is frequently prescribed to counteract the hypervigilance and agitation seen in acute stimulant use/overuse. Bradycardia is often present and can be a measure of withdrawal. Additionally, anhedonia and drug craving can also be present. Withdrawal lasts up to 1-3 weeks. Pharmacotherapeutics utilized in withdrawal including trazadone, benzodiazepines, and neuroleptics as part of a comprehensive treatment plan. Cocaine washout syndrome is a clinically recognized syndrome and includes extreme fatigue, sleepiness, and depression thought to be related to depletion of catecholamine reserves. Treatment is supportive in nature. confirmed by a negative urine drug test. Rewards can be monetary in the form of a gift card or voucher. 136 For cocaine use disorder, topiramate, a gamma- aminobutyrate (GABA) modulator, has shown some value when paired with psychosocial treatments such as contingency management. 137 Contraindications to topiratmate include kidney stones and glaucoma. Bupropion and naltrexone administered in combination have shown some promise in the treatment of methamphetamine use disorder. 138
Page 54
Book Code: MDCO1025
Powered by FlippingBook